# Buda Juice, Inc.: Form 10-Q for the period ended Mar 31, 2026

- Company: [Buda Juice, Inc.](/companies/buda.md) (CIK 2079720)
- Form: 10-Q
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 16:00 ET
- Period: 2026-03-31
- Accession: 0001493152-26-023043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2079720/000149315226023043/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2079720/000149315226023043/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-01-01 to 2026-03-31 | $3.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-01-01 to 2026-03-31 | $2.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2026-01-01 to 2026-03-31 | $1.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2026-01-01 to 2026-03-31 | $663.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2026-01-01 to 2026-03-31 | $593.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2026-01-01 to 2026-03-31 | $359.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-01-01 to 2026-03-31 | $388.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-01-01 to 2026-03-31 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-01-01 to 2026-03-31 | $0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-01-01 to 2026-03-31 | 12,351 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2026-01-01 to 2026-03-31 | $1.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2026-01-01 to 2026-03-31 | $218.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2026-03-31 | $19.8m | us-gaap:Cash |
| Current assets | at 2026-03-31 | $21.0m | us-gaap:AssetsCurrent |
| Total assets | at 2026-03-31 | $22.9m | us-gaap:Assets |
| Current liabilities | at 2026-03-31 | $1.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-03-31 | $1.8m | us-gaap:Liabilities |
| Long-term debt | at 2026-03-31 | $792.0k | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2026-03-31 | $21.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 13,094 characters.

The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited condensed financial statements and the related notes to those statements included under Item 1 of this Quarterly Report on Form 10-Q. For purposes of this section, “Buda Juice”, the “Company”, “we”, or “our” refer to Buda Juice, Inc. and its subsidiaries, unless the context otherwise requires. Certain figures have been rounded for ease of presentation and may not sum due to rounding.

### Cautionary Note Regarding Forward-Looking Statements

This “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements based upon current beliefs, plans, and expectations that involve risks, uncertainties, and assumptions. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth under Part II, Item 1A “Risk Factors” in this Quarterly Report on Form 10-Q. You should carefully read the “Risk Factors” section to understand the important factors that could cause actual results to differ materially from our forward-looking statements.

### Results of Operations for the Three Months Ended March 31, 2026, and 2025

The following table summarizes our results of operations for the three months ended March 31, 2026 and 2025, respectively:

*(in thousands)*

*(in thousands)*

|  | Three Months Ended March 31, 2026 | 2025 | Change Amount | Percentage |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $3,508 | $2,980 | $528 | 17.7% |
| Cost of goods sold | 2,122 | 1,642 | 480 | 29.3% |
| Gross profit | $1,386 | $1,338 | $47 | 3.5% |
| Operating expenses: |  |  |  |  |
| Delivery and handling | 130 | 128 | 2 | 1.3% |
| Selling, general and administrative | 663 | 407 | 256 | 62.9% |
| Total operating expenses | $793 | $535 | $258 | 48.2% |
| Income from operations | $593 | $803 | $(210) | -26.2% |
| Other income (expense): |  |  |  |  |
| Other income | 17 | - | 17 | -% |
| Interest income / (expense) | 137 | 13 | 124 | 956.6% |
| Income tax (expense) | (359) | (9) | (350) | 97.5% |
| Net income | $388 | $807 | $(419) | -52.0% |

For the three months ended March 31, 2026 and 2025, the Company reported net income of approximately $388 thousand and $807 thousand, respectively. The change in net income between the three months ended March 31, 2026 and 2025 reflects strong revenue growth offset by increased costs of produce, primarily citrus, as well as an increase in general and administrative costs associated with the Company’s initial public offering in January 2026. Additionally, the Company recognized an increase of $124 thousand in interest income as a result of an increase in cash balances after the IPO, though offset with an increase in income tax expense of $350 thousand after conversion from a LLC to a C-Corporation.

*Net Sales*: Net sales increased $528 thousand, or 17.7%, to $3,508 thousand for the three months ended March 31, 2026, from $2,980 thousand for the three months ended March 31, 2025. The increase was mainly driven by an increase in sales by our primary customer.

### Gross Profit

*(in thousands)*

*(in thousands)*

|  | Three Months Ended March 31, 2026 | 2025 | Change Amount | Percentage |
| --- | ---: | ---: | ---: | ---: |
| Cost of goods sold | $2,122 | $1,642 | $480 | 29.3% |
| Gross profit | 1,386 | 1,338 | 47 | 3.5% |
| Gross margin (percentage of net sales) | 39.5% | 44.9% |  |  |

*Gross Profit:* Gross profit margin was 39.5% and 44.9% for the three months ended March 31, 2026 and 2025, respectively. The decrease in gross profit margin was primarily driven by an increase in produce costs, specifically limes. In February 2026, lime costs spiked significantly following disruptions in western Mexico that interrupted normal supply routes. This resulted in the cost of limes to temporarily, but dramatically, increase throughout the remainder of the quarter. Conversely, our labor costs, as a percentage of revenue, improved by more than 1.5 percentage points year over year, helping to offset some of the increase in produce costs.

### Operating Expenses

*(in thousands)*

*(in thousands)*

|  | Three Months Ended March 31, 2026 | 2025 | Change Amount | Percentage |
| --- | ---: | ---: | ---: | ---: |
| Delivery and handling expense | $130 | $128 | $2 | 1.3% |
| Selling, general and administrative | 663 | 407 | 256 | 62.9% |
| Total operating expenses | $793 | $535 | $258 | 48.2% |

*Delivery and Handling Expense:* Delivery and handling expense was essentially flat, with a small increase of 1.3%, to $130 for the three months ended March 31, 2026.

*Selling, General and Administrative Expenses:* Selling, general, and administrative expense increased by $256 thousand, or 62.9%, to $663 thousand for the three months ended March 31, 2026, from $407 thousand for the three months ended March 31, 2025. The increase in selling, general and administrative expense was primarily driven by an increase in administrative personnel expenses, insurance, accounting and other professional fees as a result of the Company’s initial public offering in January 2026.

### Other Income / (Expense), Net

*(in thousands)*

*(in thousands)*

|  | Three Months Ended March 31, 2026 | 2025 | Change Amount | Percentage |
| --- | ---: | ---: | ---: | ---: |
| Other income | $17 | $- | $17 | -% |
| Interest income | 137 | 13 | 124 | 956.6% |
| Total other income | $154 | $13 | $141 | 1088.5% |

*Other income:* Other income was $17 thousand for the three months ended March 31, 2026, an immaterial increase of $17 from the three months ended March 31, 2025.

*Interest income:* Interest income was $137 thousand for the three months ended March 31, 2026, an increase of $124 thousand from the three months ended March 31, 2025. The increase is a result of the Company’s IPO, and underwriter over-allotment option exercise in January 2026 with net proceeds of $20,652. This was partially offset by the shareholder redemption as part of the IPO transaction in the amount of $3,750 thousand to bring the total net proceeds from all IPO related transactions to $16,902 thousand, thereby increasing the Company’s investable cash and therefore an increase in interest income.

*Income Taxes:* The Company is a Subchapter C corporation for U.S. federal and state income tax purposes. Amounts recognized as income taxes are presented within “income tax expense” in the accompanying statements of operations. The Company recognized income tax expense of $359 thousand and $9 thousand for the three months ended March 31, 2026 and 2025, respectively. The effective tax rate for the three months ended March 31, 2026 was 46.76%, compared to 1.07% for the same period in 2025. The increase in the effective tax rate was primarily attributable to the discrete recognition of deferred tax expense upon the Company’s conversion to a C-corporation on January 1, 2026. The Company did not record a valuation allowance as of March 31, 2026 due to its cumulative income position.

### Liquidity and Capital Resources

In the past few years, we have financed our operations primarily through cash generated from our business operations and proceeds on borrowings through our credit facilities. We had $19,828 thousand and $1,840 thousand of cash and cash equivalents as of March 31, 2026 and December 31, 2025, respectively.

*Working Capital:* The following table summarizes total current assets, liabilities and working capital at March 31, 2026 compared to December 31, 2025 (in thousands):

|  | March 31, 2026 | December 31, 2025 | Change |
| --- | ---: | ---: | ---: |
| Current Assets | $20,983 | $3,219 | $17,764 |
| Current Liabilities | 1,041 | 585 | 456 |
| Working Capital | $19,942 | $2,634 | $17,308 |

4

As of March 31, 2026, we had working capital of approximately $19,942 thousand as compared to working capital of $2,634 thousand as of December 31, 2025, an increase of $17,308 thousand. The increase is a result of the Company’s IPO, and underwriter over-allotment option exercise in January 2026 with net proceeds of $20,652 thousand. This was partially offset by the shareholder redemption as part of the IPO transaction in the amount of $3,750 thousand to bring the total net proceeds from all IPO related transactions to $16,902 thousand.

### Short-Term Cash Requirements

Our short-term cash requirements primarily include working capital needs to support inventory build, payroll, marketing, and other operating expenses, as well as approximately $139 thousand of lease obligations due within the next 12 months. We expect to fund these requirements with cash on hand, cash generated from operations, and borrowings under our credit facility, if needed.

### Long-Term Cash Requirements

Our long-term cash requirements include approximately $610 thousand in lease obligations due beyond 12 months, along with anticipated capital expenditures to support our planned regional production facilities. These facilities will represent material investments and are expected to be funded through a combination of operating cash flows and proceeds from the initial public offering in January 2026. We may also pursue additional equity or debt financing in order to acquire or invest in complementary business, products, and/or new IT infrastructure. In the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all.

### Lease Commitments

As of March 31, 2026, we were party to non-cancellable operating lease agreements related to our production facility and office space. Future minimum lease payments under this agreement total approximately $886 thousand, with $191 thousand due within the next 12 months and $695 thousand due thereafter through July 2030. These commitments represent a significant use of cash and we expect to fund them through a combination of existing cash balances and cash flows from operations.

### Cash Flows

The following tables summarize our sources and uses of cash (amounts in thousands):

*(in thousands)*

*(in thousands)*

| Cash flows provided by (used in) | Three Months Ended March 31, 2026 | 2025 | Change Amount | Percentage |
| --- | ---: | ---: | ---: | ---: |
| Operating activities | $1,305 | $904 | $401 | 44.3% |
| Investing activities | (218) | (139) | (79) | -56.9% |
| Financing activities | 16,901 | (1,438) | 18,339 | 1275.3% |
| Net increase / (decrease) in cash and cash equivalents | $17,988 | $(673) | $18,661 | 2771.7% |

Net cash provided by operating activities for the three months ended March 31, 2026, was approximately $1,305 compared to cash provided of $904 thousand for the same period in 2025. Net income for the three months ended March 31, 2026 and 2025 was approximately $388 thousand and $807 thousand, respectively. During the three months ended March 31, 2026, operating activities were impacted by approximately $269 thousand of additional general and administrative expenses, mainly due to the public company related expenses not incurred in prior years, including salaries and wages. In addition, the Company recognized $359 thousand of federal income tax expense provision as a result of the conversion from a LLC to a C-Corporation in preparation of the IPO. However, these additional operating outflows were partially offset by the increase of $124 thousand in interest income as a result of the increase in investable cash balances which resulted from the Company’s net IPO proceeds of $16,902 thousand.

Net cash used in investing activities for the three months ended March 31, 2026, was $218 thousand as compared to $139 thousand for the three months ended March 31, 2025. This increase of $79 thousand was a direct result of continued capital spending in the Dallas manufacturing facility in order to facilitate increase sales and continual improvement on overall operations.

Net cash received in financing activities during the three months ended March 31, 2026, was $16,901 thousand as compared to a net cash used amount of $1,438 thousand for the three months ended March 31, 2025. The Company’s IPO related transactions in January 2026 resulted in net cash proceeds of $16,902 thousand. However, during the three months ended March 31, 2025, the Company paid member distributions related to member tax pass-through liabilities in the amount of $1,438 thousand.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

### Recently Issued Accounting Pronouncements

See Note 2 of Notes to Unaudited Condensed Financial Statements for accounting pronouncements issued but not yet adopted that may impact the Company’s condensed financial position, earnings, cash flows or disclosures.

### Critical Accounting Policies and Estimates

There have been no material changes to the critical accounting estimates previously described in our Form 10-K for the fiscal year ended December 31, 2025.

## Market risk

As filed, 180 characters.

We are a smaller reporting company as defined in Regulation S-K of the Securities Exchange Act of 1934, as amended, and are not required to provide the information under this item.

## Controls and procedures

As filed, 665 characters.

### Evaluation of Disclosure Controls and Procedures

Management, including the Company’s Chief Executive Officer and Chief Financial Officer, has begun implementing the processes and controls necessary to design and evaluate disclosure controls and procedures appropriate for a public company.

### Changes in Disclosure Control Procedures

There have been no significant changes in our internal controls over financial reporting during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)).

## Risk factors

As filed, 138 characters.

There have been no material changes to the risk factors previously described in our Form 10-K for the fiscal year ended December 31, 2025.

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-023043. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.
